RCMC
AMED

RK Capital Management (Colorado)’s Amedisys AMED Stock Holding History

RK Capital Management (Colorado)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-77,545
Closed -$8.15M – 49
2022
Q2 		$8.15M Buy
77,545
+22,645
+41% +$2.89M 1.92% 23
2022
Q1 		$9.46M Buy
+54,900
New +$8.2M 1.86% 20

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RK Capital Management (Colorado)'s AMED Position: Q3 2022 in Review

RK Capital Management (Colorado) sold out of Amedisys (AMED) in Q3 2022, closing a stake of 77,545 shares — an estimated $8.15M sold.

RK Capital Management (Colorado) first reported a position in AMED in Q1 2022 and held it in 2 quarters. The position peaked at $9.46M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • RK Capital Management (Colorado) reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • RK Capital Management (Colorado) sold 77,545 Amedisys shares in Q3 2022, an estimated $8.15M.
  • RK Capital Management (Colorado) first reported a position in Amedisys in Q1 2022 and held it in 2 quarters.
  • RK Capital Management (Colorado)'s Amedisys position peaked at $9.46M in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on RK Capital Management (Colorado)'s 13F filing for Q3 2022, filed 10 Nov 2022.